Difference between revisions of "Bevacizumab (Avastin)"
Jump to navigation
Jump to search
| Line 8: | Line 8: | ||
==Diseases for which it is used== | ==Diseases for which it is used== | ||
*[[Breast cancer]] | *[[Breast cancer]] | ||
| + | *[[Central nervous system (CNS) cancer]] | ||
*[[Cervical cancer]] | *[[Cervical cancer]] | ||
*[[Colon cancer]] | *[[Colon cancer]] | ||
*[[Esophageal cancer]] | *[[Esophageal cancer]] | ||
*[[Hepatobiliary cancer]] | *[[Hepatobiliary cancer]] | ||
| + | *[[Melanoma]] | ||
| + | *[[Neuroendocrine tumors]] | ||
*[[Non-small cell lung cancer]] | *[[Non-small cell lung cancer]] | ||
*[[Ovarian cancer]] | *[[Ovarian cancer]] | ||
*[[Renal cancer]] | *[[Renal cancer]] | ||
| + | *[[Sarcoma]] | ||
*[[Unknown primary]] | *[[Unknown primary]] | ||
| + | *[[Uterine cancer]] | ||
==Information about counterfeit Bevacizumab (Avastin)== | ==Information about counterfeit Bevacizumab (Avastin)== | ||
Revision as of 02:19, 23 June 2013
General information
Class/mechanism: Monoclonal antibody that inhibits angiogenesis by binding VEGF and preventing the interaction of VEGF with its receptors (Flt-1 and KDR) on the surface of endothelial cells.[1][2][3]
Route: IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, Medscape,UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
- Breast cancer
- Central nervous system (CNS) cancer
- Cervical cancer
- Colon cancer
- Esophageal cancer
- Hepatobiliary cancer
- Melanoma
- Neuroendocrine tumors
- Non-small cell lung cancer
- Ovarian cancer
- Renal cancer
- Sarcoma
- Unknown primary
- Uterine cancer
Information about counterfeit Bevacizumab (Avastin)
- FDA's 2/14/2012 statement about counterfeit Avastin in U.S.
- Genentech's 2/14/2012 statement on counterfeit drug labeled as Avastin (Bevacizumab) in the United States - contains pictures of authentic and counterfeit product
- Authorized specialty distributors, wholesalers and specialty pharmacies for Bevacizumab (Avastin)
Patient drug information
- Bevacizumab (Avastin) patient drug information (Chemocare)[4]
- Brief patient counseling information can be found on pages 22-23 of the package insert[1]
- Bevacizumab (Avastin) patient drug information (UpToDate)[5]
References
Categories:
- Drug index
- Chemotherapy
- Antibody medications
- VEGF inhibitors
- Breast cancer medications
- Cervical cancer medications
- Colon cancer medications
- Esophageal cancer medications
- Hepatobiliary cancer medications
- Non-small cell lung cancer medications
- Ovarian cancer medications
- Renal cancer medications
- Cancer of unknown primary medications